Published by
@ShahidNShah
@ShahidNShah
0-50Software Development
Toronto, Ontario, Canada
RetiSpec employs AI for early neurodegenerative disease detection via simple eye exams. Using proprietary AI with retinal imaging cameras, they offer a non-invasive, accurate solution for early Alzheimer’s detection. Engaged in various Alzheimer’s studies, RetiSpec aims for regulatory approval for its clinically-validated test predicting amyloid burden at the point of care. The company received the Davos Alzheimer’s Collaborative grant for testing its technology in optometry settings among global applicants.
RetiSpec is a pioneering medical imaging company leveraging advanced AI for early neurodegenerative disease detection. Their innovative technology scans the eye for disease biomarkers, aiming for …
Posted Artificial Intelligence Medical Imaging
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on May 10, 2024 at 2:50pm